| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |